Nutex Health surges 11% as Q1 earnings soar on arbitration gains

Published 14/05/2025, 12:02
Nutex Health surges 11% as Q1 earnings soar on arbitration gains

HOUSTON - Nutex Health Inc. (NASDAQ:NUTX) reported first quarter earnings on Wednesday that vastly exceeded the prior year, driven largely by gains from arbitration efforts.

Nutex Health shares were up 11.17% in pre-market trading following the earnings release

The physician-led healthcare delivery company reported Q1 earnings per share of $2.56, compared to a loss of $0.08 per share in Q1 2024. Revenue surged 213.8% YoY to $211.8 million from $67.5 million.

The company said arbitration efforts through the Independent (LON:IOG) Dispute Resolution process resulted in approximately $105 million more revenue in Q1 2025 compared to Q1 2024, accounting for 73.1% of the total revenue increase.

"We are excited to provide yet another solid quarter with $14.6 million in net income, a record high gross profit of 56%, a record high $51.0 million in net cash from operating activities and a record high cash balance of $87.7 million," stated CFO Jon Bates.

Total (EPA:TTEF) visits at Nutex’s Hospital Division increased 20.5% YoY to 48,269 in Q1. The company ended the quarter with $87.7 million in cash and cash equivalents.

CEO Tom Vo noted the company is "now seeing more consistent financial results stemming from a combination of volume growth and operational efficiency, with more fair and reasonable payments from the arbitration process."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.